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Eﬀ ect of intermittent preventive treatment of malaria on 
health and education in schoolchildren: a cluster-randomised, 
double-blind, placebo-controlled trial
Siân E Clarke, Matthew C H Jukes, J Kiambo Njagi, Lincoln Khasakhala, Bonnie Cundill, Julius Otido, Christopher Crudder, Benson B A Estambale, 
Simon Brooker
Summary
Background Malaria is a major cause of morbidity and mortality in early childhood, yet its consequences for health 
and education during the school-age years remain poorly understood. We examined the eﬀ ect of intermittent 
preventive treatment (IPT) in reducing anaemia and improving classroom attention and educational achievement in 
semi-immune schoolchildren in an area of high perennial transmission.
Methods A stratiﬁ ed, cluster-randomised, double-blind, placebo-controlled trial of IPT was done in 30 primary schools 
in western Kenya. Schools were randomly assigned to treatment (sulfadoxine-pyrimethamine in combination with 
amodiaquine or dual placebo) by use of a computer-generated list. Children aged 5–18 years received three treatments 
at 4-month intervals (IPT n=3535, placebo n=3223). The primary endpoint was the prevalence of anaemia, deﬁ ned as 
a haemoglobin concentration below 110 g/L. This outcome was assessed through cross-sectional surveys 12 months 
post-intervention. Analysis was by both intention to treat, excluding children with missing data, and per protocol. 
This study is registered with ClinicalTrials.gov, number NCT00142246. 
Findings 2604 children in the IPT group and 2302 in the placebo group were included in the intention-to-treat 
analysis of the primary outcome; the main reason for exclusion was loss to follow-up. Prevalence of anaemia at 
12 months averaged 6·3% in the IPT group and 12·6% in the placebo group (adjusted risk ratio 0·52, 95% CI 
0·29–0·93; p=0·028). Signiﬁ cant improvements were also seen in two of the class-based tests of sustained attention, 
with a mean increase in code transmission test score of 6·05 (95% CI 2·83–9·27; p=0·0007) and counting sounds 
test score of 1·80 (0·19–3·41; p=0·03), compared with controls. No eﬀ ect was shown for inattentive or hyperactive-
compulsive behaviours or on educational achievement. The per-protocol analysis yielded similar results. 23 serious 
adverse events were reported within 28 days of any treatment (19 in the IPT group and four in the placebo group); 
the main side-eﬀ ects were problems of balance, dizziness, feeling faint, nausea, and/or vomiting shortly after 
treatment.
Interpretation IPT of malaria improves the health and cognitive ability of semi-immune schoolchildren. Eﬀ ective 
malaria interventions could be a valuable addition to school health programmes.
Funding Gates Malaria Partnership, the Norwegian Education Trust Fund and multidonor Education Development 
Programme Fund of the World Bank, DBL Centre for Health Research and Development, and the Wellcome 
Trust. 
Introduction
Children living in areas of high malaria transmission 
rapidly acquire immunity to malaria in early childhood; 
by the time they reach school age, the risk of clinical 
attacks and death has reduced.1–3 However, many 
school-aged children continue to harbour asymptomatic 
parasitaemia, which can cause anaemia.4 Although 
malaria might have an adverse eﬀ ect on cognition and 
education outcomes, evidence for this has so far been 
lacking,5,6 and the case for school-based malaria control 
has not been established.7–9 Historically, malaria chemo-
prophylaxis given to African schoolchildren was 
associated with lower rates of malaria parasitaemia and 
severe anaemia, fewer clinical attacks and malaria 
deaths,10,11 and reduced school absenteeism because of 
malaria.12 One randomised trial has investigated the 
eﬀ ect of clinical malaria on educational outcomes and 
provides evidence that school performance is related to 
the cumulative eﬀ ect of previous malaria attacks13 and 
that weekly chemo prophylaxis with chloroquine can 
improve school examination scores in Sri Lankan 
children.14 However, this approach faces operational 
challenges,15 and could prove less eﬀ ective in sub-Saharan 
Africa, where subclinical infections predominate. An 
alternative strategy is intermittent preventive treatment 
(IPT), which involves the periodic mass administration 
of a full therapeutic course of an antimalarial drug, 
irrespective of infection status. We undertook a 
randomised controlled trial in western Kenya to 
investigate the eﬃ  cacy of school-based IPT in reducing 
anaemia and improving classroom attention and 
educational achievement.
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Methods
Participants
This stratiﬁ ed, cluster-randomised, double-blind, 
placebo-controlled trial was done between March, 2005, 
and March, 2006, in primary schools in Bondo district, 
western Kenya. Malaria trans mission is intense and 
perennial in this region, with two seasonal peaks 
(March–May and November–December).16 By school 
age, clinical incidence declines to 0·25 episodes per 
child per year, although up to 50% of schoolchildren 
have asymptomatic malaria parasitaemia.2,3
Rural primary schools with 150 children or more, and 
over 15 children per class were eligible for inclusion. 
Schools located within 5 km from Lake Victoria were 
excluded to minimise confounding by Schistosoma 
mansoni.17 Meetings were held in participating schools to 
explain the nature and purpose of the trial to parents or 
legal guardians, and written informed consent was 
obtained. Schoolchildren with parental consent and no 
history of adverse reaction to sulfa-based drugs were 
eligible for recruitment. Children with a haemoglobin 
concentration of less than 70 g/L at baseline, or known or 
30 schools randomised
2305 included in ITT analysis 2611 included in ITT analysis 
      15 schools assigned placebo
3801 pupils invited to participate 
3231 (85%) pupils with parental consent
3223 children  enrolled in placebo group  
1394 (60%) received complete treatment
            (9 days), included in PP analysis 
1070 (41%) received complete treatment
            (9 days), included in PP analysis 
     15 schools assigned IPT
4110 pupils invited to participate 
3548 pupils (86%) with parental consent 
3535 children enrolled in IPT group 
     15 schools,
2615 children in post-intervention survey
     15 schools,
2305 children in post-intervention survey
      5 parental consent refused
565 (15%) non-response  
8 excluded:
    6 haemoglobin <70 g/L
    1 sickle-cell trait
    1 history of drug reaction
      5 died
      2 consent withdrawn
536 (17%) outmigration 
375 (12%) absent on day of post-
         intervention survey 
890 (39%) received  incomplete
          treatment (<9 days)
   2 treated for severe anaemia
19 treated for clinical malaria 
1 treated for severe anaemia
5 treated for clinical malaria
1535 (59%) received incomplete
           treatment (<9 days)
299 (8%) absent on day of post-
          intervention survey 
     3 died (1 before ﬁrst dose)
  39 consent withdrawn
579 (16%) outmigration 
13 excluded:
      7 haemoglobin <70 g/L
      5 sickle-cell trait
      1 pregnancy 
   33 parental consent refused
529 (13%) non-response  
4 missing data on number of 
    days of treatment received
Figure 1: Trial proﬁ le
ITT=intention-to-treat. PP=per-protocol.
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suspected to be homozygous for sickle-cell trait or 
pregnant were not enrolled.
The protocol was approved by the ethics review boards 
of Kenyatta National Hospital, Kenya; London School of 
Hygiene and Tropical Medicine, UK; and Danish 
National Committee on Medical Research Ethics, 
Denmark. Permissions were obtained from the Kenyan 
Ministry of Education, the District Education and Health 
Authorities, and head teachers. An independent data 
safety monitoring board monitored the trial and approved 
the analysis plan.
Procedures
We stratiﬁ ed schools into three groups according to 
school examination performance in previous years, to 
account for diﬀ erences in school quality and socio-
economic environment. Ten schools were randomly 
selected from each school-performance stratum, and 
within each stratum schools were randomly allocated to 
one of six coded drug groups by use of block 
randomisation (three pairs of either active drugs or dual 
placebo) according to a computer-generated random 
number list by an investigator (SEC) blind to drug 
group.
Children in intervention schools received IPT with one 
dose of sulfadoxine-pyrimethamine and three daily doses 
of amodiaquine on three occasions within a 12-month 
period (once each school term). IPT was ﬁ rst given in 
May, 2005, coinciding with a seasonal peak in 
transmission, and then repeated in September, 2005, and 
January, 2006. Children absent from school were not 
treated. Children in control schools received dual placebo 
tablets over 3 consecutive days on each occasion.
Study drugs and placebos were manufactured by 
Cosmos Limited (Nairobi, Kenya) and labelled 
according to six coded drug groups. The code was held 
by the manufacturers and the data safety monitoring 
board, and revealed to the investigators only after 
completion of the statistical analysis. Dosage was by 
age. Participants were observed for 30 min after drug 
intake and treatment re-administered once more if 
spitting or vomiting occurred. Active drugs and 
placebos were similar in size and shape, but diﬀ ered in 
taste. To preserve blinding, staﬀ  responsible for 
measuring health or education outcomes were unaware 
of drug group allocation, and analysis was done by a 
statistician with no previous involvement in the trial. 
Adverse events were monitored by the study team for 
3 days after each treatment, and a further 28 days 
thereafter using a passive surveillance system in 
schools and local health centres. Travel costs were 
reimbursed and treatment charges waived. Adverse 
eﬀ ects were monitored until the event was cured or 
had stabilised.
Incidence of clinical attacks was not measured, 
although a blood slide was prepared in children 
presenting with fever during school visits, and slide-
positive cases were treated for malaria in accordance 
with national guidelines. Children with a haemoglobin 
concentration less than 70 g/L were given a course of 
haematinics. S mansoni-positive children received one 
dose of praziquantel (40 mg/kg). Children in all schools 
(intervention and placebo) received mass treatment 
twice a year for soil-transmitted helminth infections 
with one dose of albendazole (400 mg).
We investigated whether intermittent clearance of 
malaria parasitaemia would increase haemoglobin 
concentrations and, as a consequence, reduce anaemia 
and contribute to improved attention in class and 
educational performance. The primary endpoint was the 
prevalence of anaemia, deﬁ ned as a haemoglobin 
concentration of less than 110 g/L, after 12 months of 
intervention. Secondary endpoints included prevalence 
and intensity of Plasmodium falciparum infection, mean 
haemoglobin concentration, sustained attention, and 
educational achievement.
Cross-sectional surveys were done in all schools in 
March, 2006, approximately 6 weeks after the last 
treatment. Finger-prick blood samples were obtained 
from all children with consent (aged 5–18 years) to 
assess haemoglobin concentration with a portable 
photometer (Hemocue, Angelholm, Sweden). Blood 
slides prepared for malaria were declared negative only 
after examination of 100 high-powered ﬁ elds. Data on 
covariates, including bednet use and household 
socioeconomic status were obtained through a 
questionnaire administered to children in classes 2–7 
(aged 7–17 years) during the ﬁ nal survey. Height and 
weight were measured, and anthropometric indices 
calculated. For logistical reasons, only children in 
classes 5 and 6 were asked to provide stool samples, 
which were examined microscopically for helminth eggs 
by use of the Kato-Katz technique.
The eﬀ ect of the intervention on cognitive abilities was 
investigated primarily by comparing diﬀ erences in test 
scores of sustained attention given to a cohort of children 
in classes 5 and 6 (aged 11–16 years). This group was 
selected for testing because they were old enough to 
understand the test instructions. Secondary education 
outcomes included behaviour in class and educational 
achievement.
Two tests of sustained attention were undertaken on 
the day preceding health assessments. Both tests were 
adapted from the TEA-Ch (tests of everyday attention 
for children) battery18 for group administration in 
groups of 15 or fewer, and given by a psychologist 
already trained in doing these tests. The tests involved 
listening to a tape and identifying diﬀ erent sounds 
(counting sounds) and numbers (code transmission). 
In the counting sounds tasks children were required to 
count a series of electronic beeps played on the tape 
recorder, with varying delays of 0·3–10 seconds between 
sounds. Sustained attention was required to keep track 
of the number of sounds counted during delays and to 
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be prepared for bursts of several consecutive sounds. In 
the code transmission tasks, a list of digits was read out 
aloud at the speed of one per second. Children were 
required to listen out for a “code”—two consecutive 
occurrences of the number 5—and then record the two 
numbers that preceded the code. A second test, included 
in the ﬁ nal survey, required children to recall the three 
numbers that preceded the code. Before each test 
children were given a warm-up activity to familiarise 
them with the tape recorder, and three practice exer-
cises. Internal reliability was high for both tests 
(Cronbach α>0·7 for counting sounds and α>0·8 for 
code transmission).
Classroom behaviour was assessed by teacher ratings 
of inattentive and hyperactive-impulsive behaviours in 
eight children randomly selected (by MCHJ) from each 
Intention-to-treat population Per-protocol population
Placebo IPT Placebo IPT
Number of children included in analysis 2305 2611 1394 1070
Mean age (years) 11·23 (3·09) 11·24 (3·05) 11·51 (2·92) 11·53 (2·85)
Sex (male) 1209/2305 (52%) 1405/2611 (54%) 708/1394 (51%) 559/1070 (52%)
History of residence in a non-malarious area 190/1952 (10%) 167/2221 (8%) 124/1239 (10%) 82/974 (8%)
Reported use of bednet by child 561/1952 (29%) 495/2215 (22%) 346/1239 (28%) 211/970 (22%)
Household ownership of bicycle 1434/1944 (74%) 1616/2222 (73%) 890/1232 (72%) 698/971 (72%)
House structure
Traditional 654/1957 (33%) 745/2231 (33%) 406/1243 (33%) 321/977 (33%)
Semi-permanent 831/1957 (42%) 874/2231 (39%) 529/1243 (43%) 386/977 (40%)
Permanent 472/1957 (24%) 612/2231 (27%) 308/1243 (25%) 270/977 (28%)
Lighting
Tin lamp only 1325/1956 (68%) 1400/2231 (63%) 839/1242 (68%) 624/976 (64%)
Hurricane lamp 577/1956 (29%) 747/2231 (33%) 369/1242 (30%) 308/976 (32%)
Electricity/other 54/1956 (3%) 84/2231 (4%) 34/1242 (3%) 44/976 (5%)
Family status
Lives with guardian 421/1957 (22%) 437/2234 (20%) 260/1243 (21%) 217/977 (22%)
Lives with one parent 371/1957 (19%) 421/2234 (19%) 231/1243 (19%) 159/977 (16%)
Lives with both parents 1165/1957 (60%) 1369/2234 (61%) 752/1243 (60%) 601/977 (62%)
Parental education†
No education 46/657 (7%) 59/711 (8%) 30/449 (7%) 32/346 (9%)
Primary education only 341/657 (52%) 359/711 (50%) 236/449 (53%) 171/346 (49%)
Secondary education 236/657 (36%) 253/711 (36%) 163/449 (36%) 121/346 (35%)
Higher education 34/657 (5%) 40/711 (6%) 20/449 (4%) 22/346 (6%)
Nutritional status at baseline†‡
Weight-for-age Z score –1·62 (1·05) –1·60 (1·11) –1·65 (1·03) –1·54 (1·08)
Height-for-age Z score –1·68 (1·02) –1·68 (1·12) –1·67 (1·02) –1·63 (1·10)
Helminth infection at follow-up§
Hookworm 74/598 (12%) 82/612 (13%) 47/396 (12%) 34/272 (13%)
Ascaris lumbricoides 28/598 (5%) 32/612 (5%) 15/396 (4%) 9/272 (3%)
Trichuris trichiura 32/598 (5%) 52/612 (8%) 18/396 (5%) 23/272 (8%)
Schistosoma mansoni 59/598 (10%) 32/612 (5%) 29/396 (7%) 15/272 (6%)
Study endpoints at baseline†
Number of children examined 1149 1330 748 637
P falciparum prevalence 465/1113 (42%) 524/1284 (41%) 278/728 (38%) 243/612 (40%)
P falciparum intensity per μL among 
slide-positive: geometric mean
1028·85 (1·30) 988·88 (1·18) 923·15 (1·26) 961·23 (1·14)
Anaemia prevalence 254/1145 (22%) 246/1326 (19%) 155/745 (21%) 104/636 (16%)
Mean haemoglobin concentration (g/L) 119·50 (15·54) 121·42 (14·47) 119·78 (15·27) 122·19 (14·13)
Data are mean (SD) or n/N (%) unless speciﬁ ed otherwise. *Data obtained at follow-up for all classes (5–18 years), apart from where indicated. †Measured at baseline among 
children who were enrolled in classes 5 and 6; also includes data for children in all classes in a randomly selected subset of 12 schools. ‡Anthropometric indices calculated on the 
basis of the 2000 Centers for Disease Control and Prevention growth charts. Weight-for-height standards were only available for children up to 121 cm in height and thus not 
calculated. Measured at baseline (ITT: 1141 placebo, 1321 IPT; PP: 744 placebo, 633 IPT). §Helminth infection was only measured among children enrolled in classes 5 and 6 at 
baseline.
Table 1: Characteristics of schoolchildren included in analyses of health outcomes*
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class by use of a computer-generated random number 
list. Behaviours were selected from the early childhood 
attention deﬁ cit disorder scale.19 Behaviours that were 
weakly correlated (<0·3) with the sum of other 
behaviour scores in piloting were deemed not to be 
strongly related to the overall trait and were dropped 
from the ﬁ nal instrument. Internal reliability was high 
(Cronbach α>0·8). Assessment of educational 
achievement focused on learning which occurred 
towards the end of the intervention year, when the 
cumulative eﬀ ect of repeated malaria treatment should 
have achieved maximum improvements in classroom 
attention. Knowledge of a content-based subject, taught 
during the last school term of the study, was measured 
in the two intervention groups. In January, 2006, 
teachers attended a 1-day training seminar to standardise 
the curriculum and teaching methods for social studies 
in classes 6 and 7. Children were tested at the end of the 
school term. A multiple choice exam was developed for 
each class. Internal reliability was adequate for both 
class exams (Cronbach α=0·62 for class 6 and α=0·59 
for class 7).
Statistical analysis
On the basis of an observed anaemia prevalence of 38% 
at baseline and coeﬃ  cient of variation between clusters 
of 0·27, a sample size of 12 schools with a total of 
889 children in each arm was estimated to provide 
80% power to detect a 30% reduction in the prevalence of 
anaemia in the intervention group compared with 
placebo at 5% level of signiﬁ cance.20 For the cognitive 
and education tests, where an intraclass correlation 
of 0·20 was assumed, a minimum of 15 schools per arm 
with 60 children assessed per school were needed to 
provide 80% power to detect an eﬀ ect size of 0·25 in the 
intervention group compared with placebo at 5% level of 
signiﬁ cance.
Data were analysed by intention to treat, excluding 
those children with missing data. A per-protocol analysis 
was also done, including only children treated on all 
three rounds and who completed the full 3-day regimen 
on each occasion, totalling 9 days of treatment. Children 
who received either haematinics for severe anaemia or 
active antimalarials for clinical malaria, or both, at any 
point during the study were excluded from the 
per-protocol analysis.
The eﬀ ect of the intervention was analysed with 
methods appropriate for a cluster-randomised trial.21 
The prevalence, or mean, in each school was calculated 
and the unadjusted risk ratio, or mean diﬀ erence 
(intervention–control), estimated in each stratum. An 
overall estimate of the eﬀ ect of IPT was obtained by 
taking a weighted average of the stratum-speciﬁ c 
estimates, the weights proportional to the number of 
schools per stratum, and 95% CIs were adjusted for 
observed between-school variance (Hayes R, London 
School of Hygiene and Tropical Medicine, personal 
Intention-to-treat population Per-protocol population
Placebo IPT Placebo IPT 
Number of children included in 
analysis
382 436 274 209
Mean age (years) 13·74 (1·17) 13·89 (1·19) 13·71 (1·18) 13·83 (1·17)
Sex (male) 196/382 (51%) 213/436 (49%) 134/274 (49%) 97/209 (46%)
History of residence in a 
non-malarious area
40/381 (10%) 47/435 (11%) 26/273 (10%) 25/208 (12%)
Reported use of bednet by child 73/380 (19%) 72/433 (17%) 51/272 (19%) 33/208 (16%)
Household ownership of 
bicycle
257/380 (68%) 290/433 (67%) 183/272 (67%) 136/208 (65%)
House structure
Traditional 132/382 (35%) 153/435 (35%) 98/274 (36%) 66/208 (32%)
Semi-permanent 164/382 (43%) 151/435 (35%) 113/274 (41%) 74/208 (36%)
Permanent 86/382 (23%) 131/435 (30%) 63/274 (23%) 68/208 (33%)
Lighting
Tin lamp only 268/382 (70%) 267/435 (61%) 193/274 (70%) 125/208 (60%)
Hurricane lamp 107/382 (28%) 152/435 (35%) 76/274 (28%) 72/208 (35%)
Electricity/other 7/382 (2%) 16/435 (4%) 5/274 (2%) 11/208 (5%)
Family status
Lives with guardian 89/382 (23%) 94/433 (22%) 60/274 (22%) 47/207 (23%)
Lives with one parent 74/382 (19%) 93/433 (21%) 53/274 (19%) 39/207 (19%)
Lives with both parents 219/382 (57%) 246/433 (57%) 161/274 (59%) 121/207 (58%)
Parental education† 
No education 24/298 (8%) 31/315 (10%) 18/213 (8%) 16/144 (11%)
Primary education only 139/298 (47%) 158/315 (50%) 93/213 (44%) 68/144 (47%)
Secondary education 117/298 (39%) 111/315 (35%) 90/213 (42%) 51/144 (35%)
Higher education 18/298 (6%) 15/315 (5%) 12/213 (6%) 9/144 (6%)
Nutritional status at baseline†‡
Weight-for-age Z score –1·75 (1·07) –1·65 (1·09) –1·73 (1·07) –1·58 (1·07)
Height-for-age Z score –1·67 (0·98) –1·63 (1·03) –1·65 (0·99) –1·62 (1·03)
Helminth infection at follow-up
Hookworm 44/357 (12%) 45/387 (12%) 29/255 (11%) 23/192 (12%)
Ascaris lumbricoides 11/357 (3%) 21/387 (5%) 6/255 (2%) 7/192 (4%)
Trichuris trichiura 15/357 (4%) 36/387 (9%) 9/255 (4%) 17/192 (9%)
Schistosoma mansoni 28/357 (8%) 18/387 (5%) 14/255 (5%) 10/192 (5%)
Study endpoints at baseline† 
Number of children 
examined
361 416 261 201
P falciparum prevalence 130/349 (37%) 139/406 (34%) 87/254 (34%) 72/195 (37%)
P falciparum intensity per μL in 
slide-positive: geometric 
mean
802·32 (1·19) 733·21 (1·14) 805·45 (1·11) 725·65 (1·12)
Anaemia prevalence 55/359 (15%) 44/416 (11%) 34/260 (13%) 24/201 (12%)
Mean haemoglobin 
concentration (g/L)
122·92 (15·26) 124·81 (13·92) 123·26 (14·57) 124·90 (14·06) 
Mean score in counting 
sounds test§
11·19 (3·02) 11·25 (3·04) 11·12 (2·99) 11·08 (3·22)
Mean score in code 
transmission test§
13·03 (4·99) 13·31 (4·99) 13·11 (4·74) 13·47 (5·00)
Data are mean (SD) or n/N (%) unless speciﬁ ed otherwise. *Data obtained at follow-up for education cohort recruited 
from classes 5 and 6 (11–16 years), except where indicated. †Measured at baseline. ‡Anthropometric indices calculated 
on the basis of the 2000 Centers for Disease Control and Prevention growth charts. Weight-for-height standards were 
only available for children up to 121 cm in height and thus not calculated. Measured at baseline (ITT: 359 placebo, 
415 IPT; PP: 260 placebo, 200 IPT). §Sustained attention tested at baseline (ITT: 345 placebo, 364 IPT; PP: 249 placebo, 
178 IPT).
Table 2: Characteristics of schoolchildren included in analyses of education outcomes* 
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communication). Eﬀ ect size for cognition was calculated 
by dividing the diﬀ erence in the mean cluster-level 
summaries by the standard deviation of individual 
values averaged across study arms. Formal hypothesis 
testing was done with stratiﬁ ed unpaired t tests. 
Standard individual-level regression analysis, which 
incorporated stratum as a ﬁ xed eﬀ ect and all covariates, 
suspected a priori to be confounders or eﬀ ect modiﬁ ers, 
except the intervention eﬀ ect, was used to calculate 
cluster-level expected values. Observed and expected 
values were compared by computing a residual, based 
on the ratio of observed to expected or the diﬀ erence 
between observed and expected, for each school. 
Adjustment for covariates was undertaken replacing 
school-level means and proportions with covariate-
adjusted residuals. Additionally, the eﬀ ect of 
intervention was assessed with adjustment for baseline 
characteristics among those children for whom baseline 
data were available. All analyses were undertaken using 
STATA version 9.2.
This study is registered with ClinicalTrials.gov, number 
NCT00142246.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, analysis, interpretation, or writing of the 
report. SEC, MCHJ, BC, and SB had full access to the 
data and made the ﬁ nal decision to submit for 
publication.
Results
The trial proﬁ le is shown in ﬁ gure 1. 4916 (73%) of 
6758 school children enrolled in the trial were examined 
in the post-intervention survey 12 months later. The 
numbers of children lost to follow-up were similar in 
IPT intervention and placebo schools (26% and 28%, 
respectively). Health outcomes for children in the 
intervention group (n=2611) and placebo group (n=2305) 
were analysed according to intention to treat. Most 
children examined post-intervention had received 
treatment on all three occasions (more than 7 days of 
treatment were completed by 1946 [75%] and 1990 [86%] 
in each group), although only 1070 (41%) of children in 
the intervention group and 1394 (60%) in the placebo 
group had received treatment on all 9 days and were 
included in the per-protocol analysis of health outcomes. 
Children lost to follow-up and those who received 
incomplete treatment had similar baseline char-
acteristics to children included in the per-protocol 
analysis (table 1 and table 2). Children in the IPT 
intervention and placebo groups were similar, although 
those in the IPT intervention group had slightly better 
nutritional status at baseline and fewer children were 
anaemic. Imbalances in helminth infection at baseline 
were successfully corrected with anthelmintic mass 
treatment and no marked diﬀ erences in prevalence of 
helminth infections existed between intervention and 
placebo groups at follow-up. 818 children (76% of the 
original education cohort in classes 5 and 6 at baseline) 
participated in the tests of sustained attention 
post-intervention (436 in the IPT group, 382 in the 
placebo group). Children lost to follow-up were similar 
to those examined post-intervention (data not shown). 
Study endpoints and nutritional status in the IPT and 
placebo groups were similar at baseline, with slight 
diﬀ erences in socioeconomic background (table 2 and 
table 3). 
At follow-up, the prevalence of anaemia among 
schoolchildren in the IPT intervention group was 
signiﬁ cantly lower than in the placebo group (table 4). 
Results of the intention-to-treat analysis show that the 
protective eﬃ  cacy of the intervention against anaemia 
was 48% (95% CI 8–71; p=0·028; table 4). The adjusted 
risk diﬀ erence was –0·06 (–0·01 to –0·11), equating to 
one case of anaemia prevented for every 16 children 
treated with IPT (95% CI 9–91 children). There were 
also fewer cases of severe anaemia (haemoglobin 
<70 g/L) in the IPT intervention group than in the 
placebo group (four and 16 cases, respectively). Similarly, 
post-intervention mean haemoglobin concentration was 
signiﬁ cantly higher among children in the intervention 
group than among controls (table 4); adjusted diﬀ erence 
5·01 g/L (95% CI 1·62–8·41; p=0·005). IPT seemed to 
beneﬁ t children across the whole distribution of 
haemoglobin concentrations, as shown by the diﬀ erent 
distributions between the two groups (ﬁ gure 2). 
Prevalence of P falciparum parasitaemia was lower 
Placebo IPT 
School exam performance in previous 3 years†‡
Lowest tertile (stratum 1) 219·55 (219·48–220·25) 205·34 (204·34–217·76)
Middle tertile (stratum 2) 246·38 (245·96–249·23) 233·47 (232·43–235·05)
Upper tertile (stratum 3) 267·81 (266·95–272·32) 291·08 (277·63–296·91)
Mean number of children enrolled per school (classes 0–7)†
School performance stratum 1 156·0 (44·20) 144·2 (50·25)
School performance stratum 2 214·6 (50·86) 250·8 (33·80)
School performance stratum 3 298·8 (161·06) 338·2 (124·12)
Quality of social science teaching during ﬁ nal term of intervention
Teacher absenteeism
Absent for >1 day 11 (73%) 10 (67%)
Number of days absent 3 days (2–8) 3·5 days (2–5)
Proportion of work completed and marked 0·16 (0·15) 0·14 (0·17)
Progression: number of lessons per week 4·25 (1·83) 6·33 (3·90)
Lesson plans: number of lesson plans per week 3·53 (2·83) 3·67 (3·29)
Number of teaching aids in use
None 4 (27%) 5 (33%)
One 1 (7%) 2 (13%)
Two or more 10 (67%) 8 (53%)
Data are mean (SD), median (IQR), or n (%). *Intention-to-treat and per-protocol populations drawn from same set of 
30 study schools (15 placebo, 15 IPT). †Five schools per strata in each treatment arm. ‡Median (IQR) of the mean pass 
rate in national primary school leaving exams (KCPE) during 3 years before intervention.
Table 3: Data on school level characteristics* for schoolchildren included in analyses of education 
outcomes
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among children receiving IPT than in those in the 
placebo group, with a protective eﬃ  cacy against 
P falciparum infection of 89% (95% CI 73–95; p=0·0002; 
table 4). The adjusted risk diﬀ erence was –0·35 
(0·30 to –0·41), equating to an average of one infection 
prevented for every three children treated with IPT 
Placebo IPT p value Risk ratio/mean 
diﬀ erence* (95% CI)
Number of 
children
Outcome Number of 
children
Outcome
Intention-to-treat analysis†
Prevalence of anaemia 
Crude‡ 2302 12·6% 2604 6·3% p=0·041 0·50 (0·26–0·97)
(Range between schools; k=0·44) (5·7–40·3%) (0·7–12·5%)
Observed/expected: adjusted for strata§ 2302 1·347 2604 0·689 p=0·034 0·51 (0·28–0·95)
Observed/expected: fully adjusted¶ 2292 1·326 2599 0·689 p=0·028 0·52 (0·29–0·92)
Mean haemoglobin concentration (g/L)
Crude‡ 2302 124·5 2604 130·1 p=0·002 5·62 (2·19–9·05)
(Range between schools; k=0·03) (111·9–128·3) (123·7–138·4)
Observed–expected: adjusted for strata§ 2302 –2·94 2604 2·68 p=0·002 5·62 (2·19–9·05)
Observed–expected: fully adjusted¶ 2292 –2·14 2599 2·88 p=0·005 5·01 (1·62–8·41)
Prevalence of P falciparum infection
Crude‡ 2294 39·7% 2584 4·6% p<0·0001 0·12 (0·05–0·27)
(Range between schools; k=0·14) (26·2–58·1%) (0·8–14·1%)
Observed/expected: adjusted for strata§ 2294 1·949 2584 0·226 p<0·0001 0·12 (0·05–0·27)
Observed/expected: fully adjusted|| 1938 2·532 2182 0·286 p=0·0002 0·11 (0·05–0·27)
Intensity of P falciparum infection (per μL)** 
Crude‡ 890 1282·5 104 2118·8 p=0·255 1·65 (0·68–4·01)
Observed–expected: adjusted for strata§ 890 –0·254 104 0·248 p=0·255 1·65 (0·68–4·01)
Observed–expected: fully adjusted|| 699 0·315 74 1·013 p=0·108 2·01 (0·85–4·77)
Per-protocol analysis††
Prevalence of anaemia 
Crude‡ 1392 12·8% 1070 5·7% p=0·027 0·44 (0·22–0·90)
(Range between schools; k=0·44) (5·5–36·4%) (0–17·9%)
Observed/expected: adjusted for strata§ 1392 1·369 1070 0·624 p=0·027 0·46 (0·23–0·91)
Observed/expected: fully adjusted¶ 1387 1·351 1068 0·633 p=0·025 0·47 (0·24–0·90)
Mean haemoglobin concentration (g/L)
Crude‡ 1392 124·8 1070 130·7 p=0·0010 5·99 (2·70–9·28)
(Range between schools; k=0·03) (114·9–128·5) (123·2–139·2)
Observed–expected: adjusted for strata§ 1392 –2·90 1070 3·09 p=0·0010 5·99 (2·70–9·28)
Observed–expected: fully adjusted¶ 1387 –2·32 1068 3·17 p=0·0023 5·49 (2·16–8·81)
Prevalence of P falciparum infection
Crude‡ 1386 39·3% 1059 3·7% p=0·0002 0·10 (0·03–0·28)
(Range between schools; k=0·18) (23·0–59·4%) (0–13·3%)
Observed/expected: adjusted for strata§ 1386 1·709 1059 0·166 p=0·0003 0·10 (0·03–0·30)
Observed/expected: fully adjusted|| 1228 2·064 957 0·189 p=0·0003 0·09 (0·03–0·29)
Intensity of P falciparum infection (per μL)**
Crude‡ 530 1110·5 38 1262·2 p=0·799 1·14 (0·41–3·18)
Observed–expected: adjusted for strata§ 530 –0·251 38 –0·123 p=0·799 1·14 (0·41–3·18)
Observed–expected: fully adjusted|| 444 0·101 32 0·210 p=0·829 1·12 (0·40–3·12)
Placebo and IPT intervention arms both contained 15 schools. *Risk ratios are presented for binary outcomes (anaemia and P falciparum occurrence), mean diﬀ erences are 
presented for haemoglobin concentrations. Ratio of geometric means are presented for P falciparum intensity among those infected. †Intention-to-treat analysis: placebo 
n=2305, range 64–382 children per school; IPT n=2611, range 70–341 children per school. ‡Crude estimates account for the cluster-randomised trial design. Prevalence was 
calculated for each school, and the percentage shown represents the mean of these cluster-speciﬁ c prevalence values. §Adjusted for stratiﬁ ed, cluster-randomised, trial 
design. ¶Fully adjusted for trial design, age, sex, age/sex interaction, and nutritional status. All covariates measured at follow-up. ||Fully adjusted for trial design, age, sex, 
age/sex interaction, bednet use, and migration history. All covariates measured at follow-up. **Geometric mean parasite density calculated in parasite-positive children only. 
††Per-protocol analysis: placebo n=1394, range 33–171 children per school. IPT n=1070, range 24–165 children per school.
Table 4: Eﬀ ect of IPT on health outcomes: anaemia, haemoglobin, and P falciparum parasitaemia
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(95% CI 2–4 children). Among the subset of children 
infected with P falciparum at follow-up, mean parasite 
density was similar in the two groups (p=0·108).
Results of the per-protocol analysis, which included 
only children who received complete treatment during 
each treatment round, were similar to those of the 
intention-to-treat analysis (table 4). Analysis was also 
repeated on the subgroup of 2471 children for whom 
haemoglobin data at baseline were available, and yielded 
similar results (data not shown), conﬁ rming that the 
observed diﬀ erences are not attributable to slight baseline 
imbalances in nutritional status. Although no formal test 
of interaction was made, we also undertook prespeciﬁ ed 
exploratory analyses to investigate the eﬀ ect of inter-
vention stratiﬁ ed by age, sex, and anaemia status at 
baseline. The eﬀ ect of IPT on anaemia did not diﬀ er by 
age-group (data not shown), but the eﬀ ect in girls was 
slightly greater than in boys (data not shown). An in-
crease in mean haemo globin was seen in all sub groups 
of children, including those who were not anaemic 
at baseline (adjusted diﬀ erence 7·42 g/L, 95% CI 
3·05–11·79; p=0·0018).
At follow-up, scores for sustained attention were 
higher in the IPT intervention group than among 
controls for the counting sounds test (adjusted mean 
diﬀ erence 1·80 [0·19–3·41; p=0·03; table 5) and the 
code transmission test (adjusted mean diﬀ erence 6·05 
[2·83–9·27]; p=0·0007). The eﬀ ect size was 1·22 
(95% CI 0·003–0·35) in the counting sounds test and 
0·86 (0·09–0·88) in the code transmission test. There 
was no diﬀ erence in mean score for inattentive or 
hyperactive-compulsive behaviours (table 5) or mean 
educational achievement test scores (table 6) between 
study groups.
Seven children died during the 12-month intervention 
period: two in the IPT intervention group and ﬁ ve in the 
placebo group. Cause of death was investigated, but 
could not be reliably ascertained in all cases. 23 serious 
adverse events were reported within 28 days after any 
mass treatment (includes children admitted for 
observation): 19 in the intervention group (of which 
three were judged to be possibly associated with 
treatment) and four in the control group. The most 
common serious adverse events were problems of 
balance, dizziness, feeling faint, nausea, or vomiting, 
which all occurred within 5 h of treatment. There was 
only one report of a severe skin reaction, which occurred 
in the placebo group. A further 13 adverse events were 
graded as moderate: six in the intervention group and 
seven in the placebo group. Mild events, such as nausea, 
headache, and prurititis, were more frequent among 
children receiving active drugs than among controls 
(49 and 33 reports, respectively).
Discussion
This trial has shown that school-based delivery of IPT 
once per term markedly reduced the prevalence of 
anaemia and asymptomatic parasitaemia in semi-
immune school children in Kenya. We also show a 
beneﬁ cial eﬀ ect of malaria treatment on sustained 
attention of schoolchildren. Although only 73% of 
enrolled children were followed up, there were no 
marked diﬀ erences in background characteristics or 
follow-up rates between study groups, suggesting that 
treatment eﬀ ects were not caused by sample bias. 
Children receiving IPT were less likely to complete the 
full 3-day regimen, possibly because of the bitter taste 
of amodiaquine, but there was little evidence that this 
introduced bias since the characteristics of children 
who received complete and incomplete treatment were 
similar. Additionally, twice yearly anthelmintic treat-
ment was given to all children (intervention and 
control), reducing helminth infection and anaemia in 
both groups from initial baseline levels. The resultant 
similarities in levels of helminth infection be tween 
study groups at follow-up, as well as nutritional status, 
provide convincing evidence that the effect on an-
aemia was mainly caused by reductions in malaria 
parasitaemia.
Our ﬁ ndings are consistent with earlier observations 
that insecticide-treated bednet use is associated with 
reduced anaemia in adolescent schoolgirls,22 suggesting 
that malaria control could have an important role in 
preventing anaemia in school-aged children. The size of 
the protective eﬀ ect of IPT against anaemia is markedly 
greater than the protective eﬀ ects seen in previous trials 
of anthelmintic treatment.23–25 The eﬀ ect is also 
comparable with, or larger than, reductions in the rates 
of anaemia seen following iron supplementation.26–29 
Notably, previous trials often report that either young 
children or anaemic children beneﬁ t most from 
intervention. However, in our study the protective eﬀ ect 
of the intervention against anaemia did not diﬀ er among 
age-groups, and signiﬁ cant improvements in mean 
haemoglobin concentrations were seen in children who 
were not classiﬁ ed as anaemic at baseline. This eﬀ ect 
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Figure 2: Distribution of haemoglobin concentrations among children, according to treatment 
(intention-to-treat population)
Individual-level data are presented; distribution does not take into account the clustering of children within schools.
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could have been achieved through the clearance of 
asymptomatic infections that would otherwise go 
untreated, thereby providing a window for haematological 
recovery. Decreased rates of destruction and removal of 
parasitised red blood cells, and improvements in the 
rate of erythrocyte production in the bone marrow30 
during parasite-free periods might contribute to 
improvements in haemoglobin concentration and 
anaemia. Long-acting drugs, such as sulfadoxine-
pyrimethamine, could also provide a period of 
prophylaxis immediately after treatment.31
Concerns that chemoprevention might impede the 
development of antimalarial immunity and lead to 
rebound morbidity15 might be less relevant in the 
age-group studied here, especially under intense 
transmission where early exposure promotes rapid 
acquisition of immunity before reaching school age. 
Treatment at 4-month intervals permits reinfection, 
maintaining levels of exposure-dependent immunity. 
Studies undertaken after completion of the trial showed 
the IPT strategy to be well accepted by teachers, parents, 
and schoolchildren (data not shown). Few serious adverse 
events attributable to study medication were recorded, 
and most symptoms were mild and self-limiting. 
Nonetheless, their occurrence in healthy asymptomatic 
children is not desirable.
Placebo IPT p value Diﬀ erence in means 
(95% CI)
Number of 
children tested
Mean score Number of 
children tested
Mean score
Intention-to-treat analysis
Counting sounds (maximum score 20)*
Crude† 378 15·41 433 16·01 p=0·048 0·60 (0·01 to 1·19)
(Range between schools; k=0·03) (13·47–16·40) (14·63–17·30)
Observed–expected: adjusted for strata‡ 378 –0·329 433 0·266 p=0·048 0·60 (0·01 to 1·19)
Observed–expected: fully adjusted§ 328 1·405 351 3·208 p=0·030 1·80 (0·19 to 3·41)
Code transmission (maximum score 40)¶
Crude† 368 23·28 423 27·20 p=0·019 3·92 (0·70 to 7·14)
(Range between schools; k=0·15) (16·87–31·00) (19·50–33·62)
Observed–expected: adjusted for strata‡ 368 –1·862 423 2·058 p=0·019 3·92 (0·70 to 7·14)
Observed–expected: fully adjusted§ 323 0·572 342 6·624 p=0·0007 6·05 (2·83 to 9·27)
Teacher-rated score for inattentive or hyperactive-compulsive behaviours (maximum score 38)||
Crude† 137 11·67 126 10·90 p=0·543 –0·77 (–3·36 to 1·82)
Observed–expected: adjusted for strata‡ 137 0·170 126 –0·729 p=0·481 –0·90 (–3·49 to 1·69)
Observed–expected: fully adjusted** 134 0·204 120 0·057 p=0·910 –0·15 (–2·81 to 2·52)
Per-protocol analysis
Counting sounds (maximum score 20)*
Crude† 272 15·48 209 16·14 p=0·097 0·66 (–0·13 to 1·45)
(Range between schools; k=0·02) (13·14–16·33) (13·00–17·70)
Observed–expected: adjusted for strata‡ 272 –0·255 209 0·407 p=0·097 0·66 (–0·13 to 1·45)
Observed–expected: fully adjusted§ 238 1·403 173 3·530 p=0·068 2·13 (–0·17 to 4·42)
Code transmission (maximum score 40)¶
Crude† 264 23·32 205 27·72 p=0·013 4·40 (1·01 to 7·80)
(Range between schools; k=0·16) (15·60–31·20) (17·86–33·40)
Observed–expected: adjusted for strata‡ 264 –2·155 205 2·249 p=0·013 4·40 (1·01 to 7·80)
Observed–expected: fully adjusted§ 234 0·471 169 7·214 p=0·0016 6·74 (2·84 to 10·65)
Teacher-rated score for inattentive or hyperactive-compulsive behaviours (maximum score 38)||
Crude† 106 11·58 68 10·62 p=0·537 –0·96 (–4·11 to 2·19)
Observed–expected: adjusted for strata‡ 106 –0·135 68 –1·499 p=0·381 –1·36 (–4·52 to 1·79)
Observed–expected: fully adjusted** 105 –0·019 67 –0·457 p=0·818 –0·44 (–4·33 to 3·45)
Placebo and IPT intervention arms both contained 15 schools. *Test included 20 counting sounds tasks, with up to 30 sounds per task. The total score was the number of times the 
sounds were counted correctly. †Crude estimates account for the cluster-randomised trial design. ‡Adjusted for stratiﬁ ed, cluster-randomised, trial design. §Fully adjusted for strata, 
age, sex, class, baseline haemoglobin concentration, and sustained attention score at baseline. Baseline haemoglobin concentration and baseline sustained attention scores were 
not available for all children. ¶Test included two tests, in which children were required to record the two or three numbers, respectively, that preceded the code. Each test comprised 
20 sets of code transmission targets. The total score was the number of times the target digits were correctly identiﬁ ed. ||Data available for children in 14 schools in each treatment 
arm in per-protocol analysis; and for 14 schools in placebo arm in intention-to-treat analysis. **Fully adjusted for strata, age, sex, class, baseline haemoglobin concentrations. 
Baseline haemoglobin was not available for all children. Since attention function was only assessed post-treatment, no adjustments could be made for attention at baseline.
Table 5: Eﬀ ect of IPT on cognition: attention in class
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Malaria early in life has been shown to impair later 
cognitive performance32,33 and clinical malaria aﬀ ects 
school performance.13,14 Our results show that 
asymptomatic infection can also aﬀ ect cognitive 
performance and that treatment against asymptomatic 
malaria improves sustained attention. However, by 
contrast with the Sri Lankan study,14 we did not ﬁ nd an 
improvement in educational achievement. Mean scores 
were generally low, suggesting that examined knowledge 
improved insuﬃ  ciently in both placebo and intervention 
groups for a diﬀ erence between them to be detected. 
Other possible reasons include low statistical 
power (<20%) because of greater than expected 
school-level clustering of educational achievement 
scores, short duration of follow-up, and the limited 
number of schoolchildren tested. Clinical attacks are 
less common in our population, which might also 
explain the diﬀ erence between this and the Sri Lankan 
study.14
The mechanism for the eﬀ ect on cognition is not 
known, but it is possible that raised haemoglobin 
concentra tions had a role in improving attention. There 
is strong evi dence that iron-deﬁ ciency anaemia leads to 
impaired cogni tive function,34 although the cognitive 
eﬀ ect of anaemia due to causes other than iron deﬁ ciency 
is less well under stood.32 Among many school health 
and nutrition interven tions previously assessed, only 
iron supplementation35 and malaria prevention (in Sri 
Lanka14 and the current study) have shown substantial 
improvements in cognitive function of around 0·5 SD or 
greater.36  
This large ﬁ eld trial, using a randomised design, 
enabled the eﬀ ect of malaria on sustained attention to 
be demonstrated, and provides strong evidence of a 
link between asymptomatic malaria and cognition. We 
did not, however, do an extensive battery of cognitive 
tests, and cannot determine whether asymptomatic 
malaria aﬀ ects other aspects of cognitive function. 
Neither did we examine the eﬀ ect of clinical attacks or 
absenteeism on anaemia or cognitive function. In other 
settings where the incidence of clinical attacks in 
schoolchildren is higher, this could adversely aﬀ ect 
school performance and absenteeism. Knowledge of 
the eﬀ ect of malaria on school performance and 
education is far from complete, but our ﬁ ndings 
provide suﬃ  cient evidence to indicate that this warrants 
more attention.
School health programmes provide an eﬀ ective 
vehicle to control anaemia and improve educational 
outcomes of school-aged children living in developing 
countries.37 The pronounced eﬀ ects of the IPT 
intervention on anaemia and malaria parasitaemia, and 
the eﬀ ect on sustained attention, highlight the issue of 
the continued, and often unrecognised, malaria burden 
Placebo IPT p value Diﬀ erence in means 
(95% CI)
Number of 
children tested
Mean score Number of 
children tested
Mean score
Intention-to-treat analysis
Social science exam: standard 6 (maximum score 39)*
Crude† 240 16·20 263 16·27 p=0·951 0·07 (–2·36 to 2·50)
Observed–expected: adjusted for strata‡ 240 –0·002 263 0·071 p=0·951 0·07 (–2·36 to 2·50)
Observed–expected: fully adjusted§ 200 1·893 250 1·440 p=0·747 –0·45 (–3·32 to 2·41)
Social science exam: standard 7 (maximum score 34)*¶
Crude† 198 14·78 232 15·60 p=0·305 0·83 (–0·80 to 2·46)
Observed–expected: adjusted for strata‡ 198 –0·399 232 0·380 p=0·333 0·78 (–0·85 to 2·41)
Observed–expected: fully adjusted§ 137 3·815 195 3·964 p=0·938 0·15 (–3·75 to 4·05)
Per-protocol analysis
Social science exam: standard 6 (maximum score 39)*
Crude† 167 16·26 119 16·66 p=0·774 0·40 (–2·46 to 3·26)
Observed–expected: adjusted for strata‡ 167 –0·419 119 –0·017 p=0·774 0·40 (–2·46 to 3·26)
Observed–expected: fully adjusted§ 144 1·583 116 1·193 p=0·784 –0·39 (–3·29 to 2·51)
Social science exam: standard 7 (maximum score 34)*¶
Crude† 146 14·71 120 15·41 p=0·362 0·71 (–0·87 to 2·28)
Observed–expected: adjusted for strata‡ 146 –0·606 120 0·018 p=0·421 0·62 (–0·95 to 2·20)
Observed–expected: fully adjusted§ 105 3·856 103 3·512 p=0·867 –0·34 (–4·53 to 3·84)
Placebo and IPT intervention arms both contained 15 schools. *Total number of correctly answered questions in a multiple-choice exam, speciﬁ c to curriculum taught in each 
year group. †Crude estimates account for the cluster-randomised trial design. ‡Adjusted for stratiﬁ ed, cluster-randomised, trial design. §Fully adjusted for strata, age, sex, 
teacher absenteeism, quality of schooling, and baseline haemoglobin concentration. Baseline haemoglobin concentration was not available for all children. Social science 
exams were not carried out at baseline. ¶Data available for children in 14 schools in the placebo arm. 
Table 6: Eﬀ ect of IPT on educational achievement
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among school-aged children in Africa and the potential 
of school-based programmes for tackling the problem.9 
Our ﬁ ndings also illustrate the possible gains of 
integrating malaria control into broader school health 
programmes.38 These results now need to be replicated 
in diﬀ erent epidemiological settings. Further research 
is also needed to investigate the operational feasibility 
of the approach, and any long-term educational 
beneﬁ ts.
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